THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Stock
Total 13F shares
1,375,500
Share change
-263,540
Total reported value
$441,884
Price per share
$0.32
Number of holders
13
Value change
-$112,243
Number of buys
6
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q1 2020

As of 31 Mar 2020, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,375,500 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, Snowden Capital Advisors LLC, BlackRock Inc., NORTHERN TRUST CORP, and VANGUARD GROUP INC. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.